Structure--activity and metabolism studies on organophosphate teratogens and their alleviating agents in developing hen eggs with special emphasis on Bidrin.
D000014:Abnormalities, Drug-Induced; D000015:Abnormalities, Multiple; D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D002642:Chick Embryo; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D008745:Methylation; D009243:NAD / Q000627:therapeutic use; D009249:NADP / Q000627:therapeutic use; D009536:Niacinamide / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000378:metabolism / Q000627:therapeutic use*; D009711:Nucleotides / Q000627:therapeutic use; D010756:Phosphoric Acids / Q000494:pharmacology*; D010759:Phosphorus Isotopes; D013997:Time Factors
D002087:Butyrates; D002800:Cholinesterase Inhibitors; D009539:Nicotinic Acids; D009711:Nucleotides; D010756:Phosphoric Acids; D010759:Phosphorus Isotopes; D009243:NAD; D009536:Niacinamide; D009249:NADP